February 13, 2013 / 6:06 AM / in 4 years

BRIEF-FDA grants priority review for Bayer's radium-223 dichloride

1 Min Read

FRANKFURT, Feb 13 (Reuters) - Bayer AG : * Says FDA granted priority review for radium-223 dichloride (radium-223)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below